Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Minerva Neurosciences, Inc. (NERV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Minerva Neurosciences, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.6% stake in Minerva Neurosciences Inc. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 22.5% stake in MINERVA NEUROSCIENCES, INC. |
| 02/14/2022 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 22.5% stake in MINERVA NEUROSCIENCES, INC. |
| 02/11/2022 |
SC 13G/A
| Luthringer Remy reports a 2.5% stake in Minerva Neurosciences, Inc. |
| 02/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/12/2021 |
SC 13G/A
| BlackRock Inc. reports a 1% stake in MINERVA NEUROSCIENCES INC |
| 02/16/2021 |
SC 13G/A
| Luthringer Remy reports a 7.5% stake in Minerva Neurosciences, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 5.2% stake in MINERVA NEUROSCIENCES INC |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Luthringer Remy reports a 6.8% stake in Minerva Neurosciences, Inc. |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 5.2% stake in MINERVA NEUROSCIENCES INC |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 5.4% stake in MINERVA NEUROSCIENCES INC |
| 12/10/2019 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 24.6% stake in MINERVA NEUROSCIENCES, INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. reports a 5.6% stake in Minerva Neurosciences, Inc. |
| 02/14/2018 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 1.6% stake in Minerva Neurosciences, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 7.6% stake in Minerva Neurosciences, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| Minerva Neurosciences, Inc. reports a 6.5% stake in Minerva Neurosciences, Inc. |
| 02/03/2017 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 6.9% stake in Minerva Neurosciences, Inc. |
| 02/11/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|